Patents by Inventor Thomas Brozoski

Thomas Brozoski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS
    Publication number: 20240299406
    Abstract: A pharmaceutical composition for use in treating tinnitus includes one or more pharmaceutically acceptable excipients. The composition includes a therapeutically effective amount for treating tinnitus of an active compound. The active compound is one or more of the following: sazetidine, varenicline, a pharmaceutically acceptable salt of sazetidine, a pharmaceutically acceptable salt of varenicline, a sazetidine prodrug, a varenicline prodrug, a solvate of sazetidine, a solvate of varenicline, a hydrate of sazetidine, a hydrate of varenicline, or any combination thereof.
    Type: Application
    Filed: February 8, 2024
    Publication date: September 12, 2024
    Inventors: Donald Caspary, Thomas Brozoski, Brandon Cox
  • Neuronal nicotinic acetylcholine receptor partial agonists as therapeutics for chronic tinnitus
    Patent number: 11918588
    Abstract: A method for treating a subject with symptoms of tinnitus and pharmaceutical compositions for treating tinnitus, the pharmaceutical compositions comprising one or more of the following: sazetidine, a pharmaceutically acceptable salt of sazetidine, varenicline, a pharmaceutically acceptable salt of varenicline, or any combination thereof.
    Type: Grant
    Filed: February 6, 2020
    Date of Patent: March 5, 2024
    Assignee: Board of Trustees of Southern Illinois University
    Inventors: Donald Caspary, Thomas Brozoski, Brandon Cox
  • NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR PARTIAL AGONISTS AS THERAPEUTICS FOR CHRONIC TINNITUS
    Publication number: 20220088028
    Abstract: A method for treating a subject with symptoms of tinnitus and pharmaceutical compositions for treating tinnitus, the pharmaceutical compositions comprising one or more of the following: sazetidine, a pharmaceutically acceptable salt of sazetidine, varenicline, a pharmaceutically acceptable salt of varenicline, or any combination thereof.
    Type: Application
    Filed: February 6, 2020
    Publication date: March 24, 2022
    Inventors: Donald Caspary, Thomas Brozoski, Brandon Cox